Checkpoint Therapeutics Files 8-K on Shareholder Vote Matters

Checkpoint Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyCheckpoint Therapeutics, Inc.
Form Type8-K
Filed DateMay 29, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

Related Tickers: CPTX

TL;DR

CPTX filed an 8-K for a shareholder vote. Keep an eye on outcomes.

AI Summary

Checkpoint Therapeutics, Inc. filed an 8-K on May 29, 2025, reporting on matters submitted to a vote of its security holders as of May 28, 2025. The filing details the company's corporate information, including its incorporation in Delaware and principal executive offices in Waltham, MA.

Why It Matters

This filing indicates that Checkpoint Therapeutics held or is holding a vote of its shareholders, which could pertain to significant corporate actions or governance changes.

Risk Assessment

Risk Level: low — This is a routine filing to report on a shareholder vote, not indicating immediate financial distress or significant operational changes.

Key Players & Entities

  • Checkpoint Therapeutics, Inc. (company) — Registrant
  • May 28, 2025 (date) — Date of earliest event reported
  • May 29, 2025 (date) — Date of report
  • Delaware (jurisdiction) — State of incorporation
  • Waltham, MA (location) — Address of principal executive offices

FAQ

What specific matters were submitted for a vote by Checkpoint Therapeutics' security holders?

The filing does not specify the exact matters submitted for a vote, only that such matters were reported on as of May 28, 2025.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on May 28, 2025.

What is Checkpoint Therapeutics, Inc.'s principal executive office address?

Checkpoint Therapeutics, Inc.'s principal executive office is located at 95 Sawyer Road, Suite 110, Waltham, MA 02453.

In which state was Checkpoint Therapeutics, Inc. incorporated?

Checkpoint Therapeutics, Inc. was incorporated in Delaware.

What is the SIC code for Checkpoint Therapeutics, Inc.?

The Standard Industrial Classification (SIC) code for Checkpoint Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 29, 2025 regarding Checkpoint Therapeutics, Inc..

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.